menu search

Iovance (iova) gets positive fda feedback on lung cancer drug

Based on feedback from the FDA, Iovance's (IOVA) ongoing mid-stage study on LN-145 in NSCLC could support approval under the accelerated pathway. IOVA...

July 11, 2023, 12:32 pm

Crowdstrike (crwd) up 42% ytd: will the rally extend further?

CrowdStrike's (CRWD) stock is likely to sustain the upward momentum, driven by the rising demand for cyber-security solutions amid the accelerated dig...

July 11, 2023, 10:17 am

Peabody energy is a double threat energy and steel play

Peabody Energy Co. NYSE: BTU is the nation's largest coal producer supplying energy producers like utilities and steel. The popular decarbonization mo...

July 11, 2023, 7:09 am

Biotech stock pops on reaction to experimental therapy

Iovance Biotherapeutics Inc (NASDAQ:IOVA) was last seen up 2.4% at $7.42, after the U.S. Food and Drug Administration (FDA) said a late-stage study o...

July 10, 2023, 10:22 am

Palantir: this is no bubble, ai hype should accelerate growth

Palantir stock has been a clear beneficiary of enthusiasm for AI this year. The company has sustained robust revenue growth and is set to deliver GAAP...

July 10, 2023, 9:14 am

Dow's juicy 5% yield would be a no-brainer if it weren't for the economy

Dow Inc. is a strong income play in the chemical industry with a 5.3% dividend yield, and its debt reduction efforts are expected to support accelerat...

July 9, 2023, 11:06 pm

American realty: new multifamily property agreement and undervalued

American Realty Investors, Inc. reported a significant increase in assets, net income growth, and new agreements to develop a 240-unit multifamily pro...

July 8, 2023, 2:36 am

Caribou biosciences (crbu) soars on $25m investment by pfizer

Caribou Biosciences (CRBU) gets a major boost with a $25 million equity investment by Pfizer, which will accel...

July 7, 2023, 9:23 am

Artificial intelligence 'doesn't have capability to take over', microsoft boss says

The head of artificial intelligence at Microsoft says the company will continue to accelerate its work ...

July 7, 2023, 8:00 am

Rivian drives past obstacles, accelerates production

Rivian's impressive strides in production, overcoming supply chain challenges and expanding into new markets, position them as a frontrunner in the el...

July 6, 2023, 6:30 pm

Enterprise products partners: top pick in energy as distribution growth accelerates

Enterprise Products Partners L.P. has gone nowhere for over a decade. Units yield 7.4% and distribution growth is set to ...

July 6, 2023, 3:17 pm

Better buy: medtronic vs. intuitive surgical

Medtronic is going through an "aggressive transformation" to accelerate growth. In the robotic surgery ...

July 6, 2023, 8:30 am

Natural gas services pushes ahead despite the headwinds

Natural Gas Services has kept its compressor units and horsepower stable in Q1 despite energy pricing challenges and has increased its FY2023 capital ...

July 6, 2023, 7:38 am

Fis accelerates plan to split in two with deal to sell worldpay to gtcr at a valuation of $18.5 billion

Fidelity National Information Services Inc. FIS said Thursday it is accelerating its plan to split into two companies with an agreement to sell a majo...

July 6, 2023, 7:05 am

Tiny: first look at this holding company

Canada-based Tiny specializes in acquiring and investing in businesses in the technology and eCommerce sectors, particularly within the Shopify partne...

July 6, 2023, 2:24 am

Correlate infrastructure partners and edge renewable partners launch joint venture targeting $100m initial capital deployment to accelerate microgrid development

BOISE, Idaho, July 05, 2023 (GLOBE NEWSWIRE) — Correlate Infrastructure Partners Inc. (OTCQB: CIPI) is excited to announce that it has entered into ...

July 5, 2023, 8:30 pm

Enterprise products partners: a significantly undervalued 7.4% yield with tailwinds

Enterprise Products Partners LP, a Master Limited Partnership, offers a robust yield of 7.4% and a strong track record of distribution growth, making ...

July 5, 2023, 3:26 pm

Spero therapeutics: the multi-asset pipeline could outpace the tebipenem hbr deal with gsk

Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreem...

July 5, 2023, 3:06 pm

Salesforce (crm) surges 60% ytd: what's behind this rally?

Salesforce (CRM) rides high on the growing demand for its solutions amid accelerated cloud adoption and digital transformation....

July 5, 2023, 10:47 am

Sarepta therapeutics completes sale of priority review voucher for $102 million

Sarepta Therapeutics Inc. SRPT, -0.90% said Wednesday it has completed the sale of its Rare Pediatric Disease Priority Review Voucher for $102 million...

July 5, 2023, 8:37 am


Search within

Pages Search Results: